NCT00004450View on ClinicalTrials.gov

Randomized Study of Beta Interferon and Thalidomide in Patients With Adrenoleukodystrophy

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 1998

Study Completion Date

November 30, 2000

Conditions
Adrenoleukodystrophy
Interventions
DRUG

glyceryl trierucate

DRUG

glyceryl trioleate

DRUG

interferon beta

DRUG

thalidomide

All Listed Sponsors
collaborator

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

OTHER

lead

FDA Office of Orphan Products Development

FED

NCT00004450 - Randomized Study of Beta Interferon and Thalidomide in Patients With Adrenoleukodystrophy | Biotech Hunter | Biotech Hunter